Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Neoplasm, Residual × Rituximab × 90 days × Clear all

Sponsor

Conditions

Lymphoma, Large B-Cell, Diffuse 35 Lymphoma, Follicular 25 Leukemia, Lymphocytic, Chronic, B-Cell 25 Lymphoma 20 Lymphoma, Mantle-Cell 19 Lymphoma, B-Cell, Marginal Zone 19 Lymphoma, Non-Hodgkin 18 Lymphoma, B-Cell 13 Recurrence 11 Burkitt Lymphoma 11 Neoplasms 9 Precursor Cell Lymphoblastic Leukemia-Lymphoma 8 Waldenstrom Macroglobulinemia 7 Leukemia 5 Leukemia, Hairy Cell 4 Hodgkin Disease 3 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 2 Lymphoproliferative Disorders 2 Leukemia, Biphenotypic, Acute 2 Leukemia, B-Cell 2 Hematologic Diseases 2 Heart Failure 2 Dendritic Cell Sarcoma, Interdigitating 2 beta-Thalassemia 1 Thalassemia 1 Prostatic Neoplasms 1 Plasmablastic Lymphoma 1 Myelodysplastic Syndromes 1 Multi-centric Castleman's Disease 1 Macular dystrophy, corneal type 1 1

Interventions

Cyclophosphamide 5 fludarabine 4 Dexamethasone 4 blinatumomab 3 Lenalidomide 3 pembrolizumab 2 fludarabine phosphate 2 Cytarabine 2 venetoclax 1 tislelizumab 1 tisagenlecleucel 1 tetrathiomolybdate 1 tagraxofusp 1 relugolix 1 obinutuzumab 1 nilotinib 1 ixazomib 1 isatuximab 1 inavolisib 1 giredestrant 1 enzalutamide 1 daratumumab 1 abemaciclib 1 Vincristine 1 Transplantation 1 Radiotherapy 1 Neoadjuvant Therapy 1 Monatide (IMS 3015) 1 Methotrexate 1 Melphalan 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡